BackActuate Therapeutics Overview

Actuate Therapeutics Receivables

Track Actuate Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average / median

Loading

Actuate Therapeutics Receivables History

Loading

Actuate Therapeutics vs. peers: Receivables Comparison

Loading

Actuate Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Actuate Therapeutics (ACTU) FAQ

As of the most recent data (March 2026), ACTU shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACTU's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Actuate Therapeutics is outperforming or lagging.

Tracking ACTU's receivables over time shows whether Actuate Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Actuate Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.